Federated Hermes
ASMB icon

Federated Hermes’s Assembly Biosciences ASMB Stock Holding History

Federated Hermes’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,904
Closed -$525K – 2043
2026
Q1 		$525K Sell
18,904
-6,490
-26% -$185K ﹤0.01% 1280
2025
Q4 		$864K Hold
25,394
– – ﹤0.01% 1165
2025
Q3 		$650K Hold
25,394
– – ﹤0.01% 1274
2025
Q2 		$460K Hold
25,394
– – ﹤0.01% 1353
2025
Q1 		$243K Hold
25,394
– – ﹤0.01% 1464
2024
Q4 		$401K Hold
25,394
– – ﹤0.01% 1368
2024
Q3 		$384K Hold
25,394
– – ﹤0.01% 1376
2024
Q2 		$348K Hold
25,394
– – ﹤0.01% 1386
2024
Q1 		$338K Sell
25,394
-1
-0% -$12 ﹤0.01% 1408
2023
Q4 		$250K Sell
25,395
-3,093
-11% -$29.4K ﹤0.01% 1479
2023
Q3 		$303K Hold
28,488
– – ﹤0.01% 1461
2023
Q2 		$393K Sell
28,488
-1,764
-6% -$21.7K ﹤0.01% 1442
2023
Q1 		$305K Sell
30,252
-884
-3% -$14.9K ﹤0.01% 1522
2022
Q4 		$486K Sell
31,136
-3
-0% -$51 ﹤0.01% 1374
2022
Q3 		$613K Hold
31,139
– – ﹤0.01% 1273
2022
Q2 		$785K Sell
31,139
-636
-2% -$14.6K ﹤0.01% 1233
2022
Q1 		$785K Sell
31,775
-13,599
-30% -$292K ﹤0.01% 1325
2021
Q4 		$1.27M Buy
45,374
+174
+0.4% +$5.71K ﹤0.01% 1188
2021
Q3 		$1.89M Buy
45,200
+1,560
+4% +$65.4K ﹤0.01% 1062
2021
Q2 		$2.03M Buy
43,640
+43,362
+15,598% +$2.15M ﹤0.01% 1093
2021
Q1 		$15K Buy
+278
New +$18.4K ﹤0.01% 1976
2018
Q2 		– Sell
-1,866
Closed -$1.1M – 2195
2018
Q1 		$1.1M Hold
1,866
– – ﹤0.01% 1200
2017
Q4 		$1.01M Buy
1,866
+618
+50% +$280K ﹤0.01% 1218
2017
Q3 		$523K Buy
1,248
+1,206
+2,871% +$370K ﹤0.01% 1353
2017
Q2 		$10K Sell
42
-15
-26% -$4.22K ﹤0.01% 1833
2017
Q1 		$17K Buy
57
+5
+10% +$1.23K ﹤0.01% 1755
2016
Q4 		$7K Buy
+52
New +$7.73K ﹤0.01% 1882

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Federated Hermes's ASMB Position: Q2 2026 in Review

Federated Hermes sold out of Assembly Biosciences (ASMB) in Q2 2026, closing a stake of 18,904 shares — an estimated $525K sold.

Federated Hermes first reported a position in ASMB in Q4 2016 and held it in 27 quarters. The position peaked at $2.03M in Q2 2021. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Federated Hermes reported no remaining Assembly Biosciences position as of Q2 2026 after selling out during the quarter.
  • Federated Hermes sold 18,904 Assembly Biosciences shares in Q2 2026, an estimated $525K.
  • Federated Hermes first reported a position in Assembly Biosciences in Q4 2016 and held it in 27 quarters.
  • Federated Hermes's Assembly Biosciences position peaked at $2.03M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.